You are here: Industry Insights > Apotex

News List

FDA Update on Chantix with Nitrosamine Impurity americanpharmaceuticalreview
July 20, 2021
To ensure patient access to Chantix (varenicline), the FDA will not object to certain manufacturers temporarily distributing varenicline tablets containing N-nitroso-varenicline above FDA’s acceptable intake limit of 37 ng per day but below the ...
Apotex Recalls Enoxaparin Sodium Injection americanpharmaceuticalreview
February 10, 2021
Apotex is voluntarily recalling two batches of Enoxaparin Sodium Injection, USP to consumer level due to a packaging error resulting in some syringes barrels containing 150 mg/mL markings (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL ...
Apotex Names New Presdient, Chief Executive Officer americanpharmaceuticalreview
December 21, 2020
Apotex has announced its board of directors has appointed Peter Hardwick as President & Chief Executive Officer of Apotex Corp., effective immediately.
Teva Charged in Ongoing Criminal Antitrust Investigation americanpharmaceuticalreview
September 07, 2020
Teva Pharmaceuticals USA has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the Department of Justice announced.
Supernus Sues Apotex for Infringement of Oxtellar XR® Patents americanpharmaceuticalreview
July 07, 2020
Supernus Pharmaceuticals announced it has sued generic drug maker Apotex Inc. and Apotex Corp. for infringement of nine patents covering its antiepileptic drug Oxtellar XR®.
Apotex Issues Recall of Metformin Hydrochloride Extended-Release Tablets 500mg americanpharmaceuticalreview
June 05, 2020
Apotex is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level.
Novartis, Amneal, Apotex offer hydroxychloroquine for Covid-19 pharmaceutical-technology
March 24, 2020
Novartis is set to donate up to 130 million doses of generic hydroxychloroquine to help fight the Covid-19 coronavirus infection that led to a global pandemic.
LIFEPharma signs agreement with Apotex biospectrumasia
October 10, 2019
LIFEPharma will manufacture nine products in its facility in Dubai – which will then be exported for commercialization in Canada – becoming the first UAE company to export generics to the North American market.
Apotex could fetch up to $3 billion as sources suggest sale on the cards firstwordpharma
April 08, 2019
According to sources close to the matter, Apotex is considering a full or partial sale of its business……
After Apotex founder's murder, family weighs sale worth up to $3B fiercepharma
April 08, 2019
It’s been a tumultuous year and a half at Canadian generics maker Apotex, and now the company is weighing a sale, Bloomberg reports.

Previous page 1 2 Next page